Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 13, 2011 Arundhati Parmar	FDA OKs Study Design on Medtronic Product That Firm Is Bullish On The product is the Simplicity catheter-based system to treat hypertension, or high blood pressure.
The Motley Fool June 27, 2011 Arundhati Parmar	St. Jude Medical's Migraine Treatment: Good for Europe, but Not the U.S.? St. Jude won't comment on whether the company plans to do a second clinical trial or whether it is confident it will win approval from the FDA without it.
The Motley Fool June 24, 2011 Arundhati Parmar	Data on St. Jude Migraine Treatment "Impressive" An effective migraine treatment would be very valuable for St. Jude.
The Motley Fool July 15, 2011 Arundhati Parmar	St. Jude Medical's Novel Heart Disease Diagnostic Tool Cleared in Europe St. Jude has an inventive new heart disease treatment.
The Motley Fool January 26, 2005 Stephen D. Simpson	St. Jude Is No Lost Cause The No. 3 cardiology company posts solid growth because of continuing implantable cardioverter defibrillator (ICD) market share gains.
BusinessWeek June 7, 2004 Gene G. Marcial	St. Jude's Bruise Should Clear Up Fast St. Jude Medical (STJ ) tumbled 2%, to $73, after it revealed that the FDA had delayed for a month the approval of its new Epic CRT-defibrillator.
The Motley Fool July 12, 2011 Arundhati Parmar	FDA Allows Expansion of St. Jude Study to Treat Severe Depression St. Jude moves forward with treatment for depression.
BusinessWeek March 22, 2004 Robert Barker	St. Jude: An Insider Sign To Investors? St. Jude, the patron saint of lost causes, rarely has needed to look out for his namesake, St. Jude Medical (STJ ). Since its birth in 1976, this maker of artificial heart valves, defibrillators, catheters, and sundry other cardiac devices has led a blessed life. It's in excellent health today. So why are insiders dumping the stock?
The Motley Fool April 23, 2011	St. Jude, Medtronic Execs Offer Different Views on JAMA Article's Impact An article and government investigation into implant devices may or may not have played a role in each company's performance, depending on whom you ask.
The Motley Fool July 18, 2008 Brian Orelli	St. Jude Is a Fighter The medical device maker continues to kick the competition while it's down.
The Motley Fool October 19, 2007 Billy Fisher	Keeping Pace at St. Jude Medical device maker St. Jude Medical has a strong quarter, but investors weren't impressed.
The Motley Fool April 20, 2005 Stephen D. Simpson	St. Jude's Healthy Heartbeat Medical device maker St. Jude continues to be boosted by ICD market share gains, and new businesses are coming on line, as well.
The Motley Fool July 20, 2005 Stephen D. Simpson	Hey, Jude! Party Hearty St. Jude's ICD (implantable cardioverter defibrillator) business is on fire and fueling strong profit growth for this medical device maker. Whether your cut-off makes St. Jude a mid-cap or a large-cap, this company is certainly growing -- and the stock's valuation reflects that.
The Motley Fool July 19, 2006 Stephen D. Simpson	Taking St. Jude's Pulse The ICD market is a long-term opportunity, but not a panacea. St. Jude investors should remember that this is a rough neighborhood -- product liability, FDA bureaucracy, and huge, tough competitors live here, too.
The Motley Fool April 11, 2008 Brian Orelli	St. Jude's Heartfelt Acquisition Medical-device maker St. Jude purchases tiny EP MedSystems.
The Motley Fool January 25, 2006 Stephen D. Simpson	Is St. Jude Next to Be Wooed? Can St. Jude build upon the jump-start opportunity from Guidant's troubles, or will further market share growth prove to be increasingly hard to come by? Investors, take note.
The Motley Fool April 25, 2011 Arundhati Parmar	St. Jude: New Aortic Replacement Valve Approved St. Jude gets good news.
The Motley Fool April 19, 2006 Stephen D. Simpson	St. Jude Lives and Learns Though dynamics in the ICD market caught it by surprise, this is still a quality med-tech company. Investors, take note.
The Motley Fool January 18, 2012 Dan Caplinger	Has St. Jude Medical Become the Perfect Stock? St. Jude took a big step toward perfection when it initiated a big dividend in early 2011.
The Motley Fool January 9, 2007 Billy Fisher	St. Jude's Juiced-Up Q4 The medical-device maker shows stronger vital signs. Investors, take note.
The Motley Fool April 19, 2007 Billy Fisher	A Saintly Quarter Shares of St. Jude Medical rise after the company announces a big quarter.
The Motley Fool February 8, 2006 Tim Beyers	Who's Buying Now? Sometimes, insiders are buying for all the right reasons. Who's buying now? Dominion Resources... Goodrich Petroleum... iPass... ITT Educational Services... St. Jude Medical...
The Motley Fool October 17, 2005 Stephen D. Simpson	A Stimulating Merger St. Jude will be paying $61.25 a share in cash for Advanced Neuromodulation Systems, a robust 30% premium to Friday's closing price. This deal demonstrates that large med-tech players may still be on the prowl for avenues into fast-growing new markets.
The Motley Fool July 25, 2011 Jason Moser	Rising Star Buy: St. Jude Medical It's a good time to jump in on this medical-device maker.
The Motley Fool October 17, 2005 Stephen D. Simpson	A Busy Day for St. Jude In addition to announcing a major acquisition, St. Jude also reported very solid financial results for the third quarter. Analysts keep raising the bar, and the medical equipment company continues to surpass it.
American Family Physician September 1, 2003 Magill et al.	New Developments in the Management of Hypertension Advances in the management of hypertension have refined our understanding of systolic blood pressure, nutrition, medication selection, and hypertension in special populations.
The Motley Fool July 25, 2011 Jordan DiPietro	Should You Retire With St. Jude? I can't decide for you whether or not this is the best stock for retirement, but it has passed all four tests, which is pretty impressive.
The Motley Fool April 5, 2006 Stephen D. Simpson	St. Jude's Racing Heartbeat Slows Even though the stock got far too expensive, this is still a good company and could still be a viable target for certain large health-care companies that may be in an acquisition frame of mind.
The Motley Fool May 25, 2011 Brian Orelli	No Red Carpet for Medtronic's New CEO Omar Ishrak, Medtronic's newly-appointed CEO, looks like he has his work cut out for him trying to get the medical-device maker growing again.
The Motley Fool November 18, 2004 W.D. Crotty	Medtronic Down, Not Out Internal defibrillator maker's earnings growth rate is slowing down, but its future looks healthy.
American Family Physician October 1, 2002 Konzem et al.	Controlling Hypertension in Patients with Diabetes Hypertension and diabetes mellitus are common diseases in the United States. Patients with diabetes have a much higher rate of hypertension than would be expected in the general population. Regardless of the antihypertensive agent used, a reduction in blood pressure helps to prevent diabetic complications.
The Motley Fool January 6, 2005 Stephen D. Simpson	Can Medtronic Still Quicken the Pulse? While increased competition looms for the medical device maker, a shareholder update looks to the past.
BusinessWeek May 29, 2006 Gene G. Marcial	Will Medtronic's Pulse Quicken? Some investors say Medtronic may beat analysts' consensus forecast.
American Family Physician May 1, 2006 Luma & Spiotta	Hypertension in Children and Adolescents The prevalence and rate of diagnosis of hypertension in children and adolescents appear to be increasing. Most childhood hypertension, particularly in preadolescents, is secondary to an underlying disorder.
The Motley Fool November 21, 2006 Ryan Fuhrmann	Shocking Results at Medtronic Favorable earnings boost shares of this medical equipment maker -- but are they too high already?
The Motley Fool May 26, 2005 Stephen D. Simpson	A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges?
American Family Physician January 1, 2003 Edward Onusko	Diagnosing Secondary Hypertension Secondary hypertension is elevated blood pressure that results from an underlying, identifiable, often correctable cause. Only about 5 to 10 percent of hypertension cases are thought to result from secondary causes. The ABCDE mnemonic can be used to help determine a secondary cause of hypertension.
The Motley Fool October 12, 2004 Jeff Hwang	The Phantom Stock Split "Boost" If St. Jude Medical's stock went up, it's not because it's worth any more.
The Motley Fool August 4, 2006 Stephen D. Simpson	Medtronic's Shock to the System Its guidance cuts rattled the med-tech industry, but long-term trends remain positive. While the going may be tougher now in the ICD space, it's still an attractive long-term opportunity, and investors may want to start looking around for bargains.
The Motley Fool June 7, 2011 Arundhati Parmar	St. Jude Medical Introduces Two Cardiac Devices in India St. Jude heads to the Subcontinent.
The Motley Fool December 9, 2011 Harsh Chauhan	Medtronic Regains Its Footing Medtronic comes up with a strong quarter.
The Motley Fool February 22, 2006 Stephen D. Simpson	Medtronic's Minor Miss Sluggish sales in several market categories might spook investors.
The Motley Fool February 17, 2009 Brian Orelli	Investors Heart Medtronic The leaner company is more lovable.
The Motley Fool October 20, 2009 Robert Steyer	The Heart Company's Disheartening Forecast Boston Scientific scaled back its full-year forecast, and the market doesn't like it.
American Family Physician August 1, 2002 Mark W. Niedfeldt	Managing Hypertension in Athletes and Physically Active Patients Athletes and other physically active patients should be screened for hypertension and given appropriate therapy if needed.
The Motley Fool May 25, 2010 Brian Orelli	Medtronic Gets Tossed Out With the Bathwater A bad day to report good news.
Pharmaceutical Executive January 1, 2012 Ben Comer	Top Medical Innovations 2012 A selection of the recent breakthrough technologies showcased at the Cleveland Clinic's Medical Innovations Summit.
The Motley Fool April 30, 2011 Arundhati Parmar	iPad Makes Medtronic More Than Just Cool Roughly 5,000 Apple iPads being used within Medtronic have kept the world's largest medical device company pretty busy developing apps.
American Family Physician June 15, 2003 Kodner & Kudrimoti	Diagnosis and Management of Acute Interstitial Nephritis Acute interstitial nephritis is an important cause of acute renal failure resulting from immune-mediated tubulointerstitial injury, initiated by medications, infection, and other causes.
The Motley Fool December 29, 2011 Harsh Chauhan	Why Medtronic Is On Course for a Happy New Year Right moves make Medtronic a good investment now.